Pyxis Oncology, Inc. (PYXS)
1.71
+0.01
(+0.59%)
USD |
NASDAQ |
Apr 13, 16:00
1.74
+0.03
(+1.75%)
After-Hours: 20:00
Pyxis Oncology EPS Diluted (Quarterly) : -0.2888 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0055 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.11M |
| Revenue (Quarterly) | 11.04M |
| Total Expenses (Quarterly) | 29.14M |
| Enterprise Value | 57.79M |
| Gross Profit Margin (Quarterly) | 52.12% |
| Profit Margin (Quarterly) | -164.0% |
| Earnings Yield | -75.06% |
| Normalized Earnings Yield | -75.06 |